Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors

NCT03915678 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

247

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor, Adult
Pancreatic Cancer
Virus-associated Tumors
Non Small Cell Lung Cancer
Melanoma
Bladder Cancer
Triple Negative Breast Cancer

Interventions

DRUG: Association atezolizumab + BDB001 + RT
DRUG: Association atezolizumab + BDB001+ RT
DRUG: Association atezolizumab + BDB001+ RT
DRUG: Association atezolizumab + BDB001 + RT
DRUG: Association atezolizumab + BDB001 + RT
DRUG: Association atezolizumab + BDB001 + RT

Sponsor

Institut Bergonié

Collaborators

[object Object]
[object Object]
[object Object]